Avantis US Small Cap Value ETF vs Axon Enterprise Inc — how do they compare? Avantis US Small Cap Value ETF trades at $127.5, while Axon Enterprise Inc trades at $602 (market cap $51.69B). The key difference: Avantis US Small Cap Value ETF is trading nearer its 52-week high, Axon Enterprise Inc nearer its low. Which is the better fit depends on your goals.
| AVUV | AXON | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $128.74 | $791.62 |
52-Week Low | $93.93 | $345.94 |
Market Cap | — | $51.69B |
Enterprise Value | — | $52.83B |
Signals from Pluang's Aura AI — not financial advice
AVUV, a U.S. small-cap value ETF, trades at $127.51, up 0.4% today, with a bullish technical signal from moving averages and neutral oscillators. Recent news highlights its strong 2026 performance, outpacing the Russell 2000, and positioning it as a diversification tool for tech-heavy portfolios. The fund benefits from a shift toward value stocks and potential rate cut tailwinds.
The outlook for AVUV is positive, driven by small-cap value momentum and investor rotation away from large-cap concentration. Key risks include sensitivity to interest rates, regional bank exposure, and higher small-cap volatility. Analyst sentiment is optimistic, with media coverage emphasizing its role in balanced long-term strategies.
AXON trades at $599.78, up 0.58% on the day, consolidating after a strong uptrend. The stock shows bullish technical signals with support near $616 and resistance at $649. Fundamentally, Q2 2026 revenue grew 35% year-over-year to $904 million, marking the tenth consecutive quarter of growth above 30%, with a net income margin of 6.19%. Analyst consensus is strongly bullish with an $685 price target, though valuation multiples remain elevated.
The outlook is positive given robust revenue growth and AI-driven expansion, but the high P/E of 265 presents a significant risk. Investors face a trade-off between strong operational execution and demanding valuations. Near-term catalysts include Q3 2026 earnings and continued execution on the $15.1B future contracted bookings pipeline.
Trailing returns across standard periods
Latest headlines on both assets
AVUV is an actively managed ETF that targets small-cap value companies in the United States. It uses a systematic, rules-based process to identify firms with low valuations and high profitability, aiming to capture the historical premiums of 'size' and 'value' while filtering for financial quality.
Read more on AVUV →Axon develops technology and weapons for law enforcement and military use. Its ecosystem includes TASER devices, body cameras, and Evidence.com, a cloud-based platform for digital evidence management.
Read more on AXON →